TAKEDA PHARMACEUTICAL COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 231.5 MXN | -3.73% |
|
-.--% | -3.42% |
| 07-03 | Blackstone selling Japan drugmaker Alinamin to MBK Partners | RE |
| 07-02 | Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 823B | ||||||
| 353B | - | - | - | - | ||
| 320B | ||||||
| 295B | ||||||
| 239B |
